Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
AMPH
REPL
Add up to 3 more stocks
AMPH
Amphastar Pharmaceuticals, Inc.
+2.13%
$25.91+0.54Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.14B
52W Range
$16.65 - $29.52
REPL
Replimune Group, Inc.
+0.76%
$13.25+0.10Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$1.11B
52W Range
$1.50 - $16.33
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 15.33 | N/A |
| Forward P/E | 8.72 | N/A |
| PEG Ratio | 0.11 | N/A |
| P/B Ratio | 1.49 | 10.54 |
| P/S Ratio | 1.56 | N/A |
| P/FCF Ratio | 7.47 | N/A |
| EV/EBITDA | 8.95 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 47.7% | 0.0% |
| Operating Margin | 15.7% | 0.0% |
| Net Margin | 10.8% | 0.0% |
| ROE | 10.2% | -281.1% |
| ROA | 4.5% | -117.7% |
| ROIC | 5.9% | -139.1% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 2.40 | 5.23 |
| Quick Ratio | 1.71 | 5.23 |
| Debt/Equity | 0.90 | 1.06 |
| Interest Coverage | 5.51 | -36.11 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.